FDA adds warning to Ozempic, Mounjaro and other GLP-1 labels
(By Alexandra Murphy for Becker’s Hospital Review) The FDA has updated the labels for all GLP-1 receptor agonists, including popular
Read More
GLP-1 drugs
Medicaid Coverage of and Spending on GLP-1s
(By Elizabeth Williams, Robin Rudowitz, and Clea Bell for The Kaiser Family Foundation Published: Nov 04, 2024) GLP-1 (glucagon-like peptide-1)
Read MoreWeight loss drugs could cost Medicare $6B a year: Study
(By Rylee Wilson for Becker’s Hospital Review) Medicare spending could increase between $3.1 billion and $6.1 billion annually if the
Read MoreMarketplace Insurers are Proposing a 7% Average Premium Hike for 2025 and Pointing to Rising Hospital Prices and GLP-1 Drugs as Key Drivers of Costs
(By Tammie Smith for The Kaiser Family Foundation published August 5, 2024) ACA Marketplace insurers are proposing a median premium
Read MoreWeight loss drugs 1 factor behind ACA premium increases: 3 things to know
(By Rylee Wilson for Becker’s Hospital Review) Premiums for plans on the ACA marketplace will rise 7% on average in
Read More